Nachrichten zur Johnson & Johnson Aktie

J&Js $8B Jury Award in Risperdal Case Cut to $6.8M by Judge

A Philadelphia judge slashes J&Js (JNJ) punitive damages in a lawsuit, which claims that the company did not warm men…

Hersteller: Keine Preiserhöhungen bei Tampons und Binden

DÜSSELDORF (dpa-AFX) - Zwei führende Hersteller von Tampons und Binden haben Berichte über Preiserhöhungen im Umfeld…

American Express, IBM, Intel, Johnson & Johnson and More Dow Stocks Reporting This Week

Um den gesamten Artikel unter feedproxy.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Judge Cuts $8 Billion J&J Jury Award to $6 Million

Um den gesamten Artikel unter marketwatch.com zu lesen, klicken Sie bitte auf die Überschrift...…

Judge Slashes Damages in J&J Risperdal Case to $6.8 Million from $8 Billion

A judge reduced the amount of punitive damages Johnson & Johnson must pay in a lawsuit over its antipsychotic Risperdal…

UPDATE 2-Judge slashes $8 bln Risperdal award against Johnson & Johnson to $6.8 mln

A Pennsylvania judge on Friday slashed to $6.8 million from $8 billion a punitive damages award against Johnson & Johnson to a…

$8 Billion Verdict in Drug Lawsuit Is Reduced to $6.8 Million

A Philadelphia judge lowered the damages in a case that claimed Johnson & Johnson played down the risks of an…

Judge reduces J&J Risperdal damages 99.9%

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Johnson & Johnson Gets Punitive Damages in Risperdal Case Reduced to $6.8 Million

The fine was initially set to $8 billion and was on top of a compensatory award totaling $680,000....…

UPDATE 1-Judge slashes $8 bln Risperdal award against Johnson & Johnson to $6.8 mln

A Pennsylvania judge on Friday slashed to $6.8 million from $8 billion a punitive damages award against Johnson & Johnson for allegedly…

Judge slashes $8 bln Risperdal award against Johnson & Johnson to $6.8 mln

A Pennsylvania judge on Friday slashed to $6.8 million from $8 billion a punitive damages award against Johnson & Johnson for allegedly…

Is Johnson & Johnson (JNJ) A Good Pick for Value Investors-

Is Johnson & Johnson (JNJ) a great pick from the value investors perspective right now? Read on to know more....…

Will J&J (JNJ) Roll Out Pharma Q4 Earnings With a Beat-

J&Js (JNJ) cancer drugs are expected to have contributed significantly to fourth-quarter 2019 earnings. Generic/biosimilar headwinds are expected to have…

Health Executives Gear Up for Change at J.P. Morgan Conference

The pharmaceutical industrys top U.S. lobbyist and executives at Johnson & Johnson, Eli Lilly and CVS Health are among those…

J&J Seeks Label Expansion for Spravato Nasal Spray in EU

J&J (JNJ) seeks label expansion for its new nasal spray, Spravato (esketamine), for an expanded patient population in Europe....…

Yield Growth-Tochter Flourish Mushroom Labs bestellt den ehemaligen Chairman von Johnson & Johnson, Jeff B. Smith, zu ihrem Board-Chairman

16. Januar 2020 - Vancouver, BC: The Yield Growth Corp. (CSE:BOSS) (OTCQB:BOSQF) (FWB:YG3) gibt bekannt, dass seine Tochtergesellschaft Flourish Mushroom…

1.446% Hot Stock verpflichtet Johnson & Johnson Top-Manager. Facebook Investor Peter Thiel investiert in Boombranche

Vancouver (www.aktiencheck.de, Anzeige) Einschätzung Strong OutperformerKurszieleKursziel 12M: 1,50 EUR Kurschance: 673% Kursziel 24M: 3,00 EUR Kurschance: 1.446%StammdatenISIN: CA98584W2067 WKN: A2PBJW Ticker: YG3 CSE: BOSSKursdatenKurs: 0,...…

Johnson & Johnson (JNJ) Outpaces Stock Market Gains: What You Should Know

Johnson & Johnson (JNJ) closed the most recent trading day at $147.01, moving +0.33% from the previous trading session....…

Johnson & Johnson Seeks Expanded Use in Europe for Depression Nasal Spray

Less than a month after first getting approved in Europe, Janssen is continuing to grow in the continent....…

Johnson & Johnson (JNJ) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

Johnson & Johnson (JNJ) possesses the right combination of the two key ingredients for a likely earnings beat in its…

J&J files application in Europe for expanded use of Spravato

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Better Buy: Johnson & Johnson vs. Merck

Which of these healthcare stocks is more likely to prevail over the long term?...…

Why Johnson & Johnson Will Survive its Latest Litigation Wave

Johnson & Johnson is no stranger to litigation. But the most recent onslaught of talcum powder lawsuits probably isnt the…

Why Johnson & Johnson (JNJ) Could Beat Earnings Estimates Again

Johnson & Johnson (JNJ) has an impressive earnings surprise history and currently possesses the right combination of the two key…

J&J to collaborate with Exonate in eye diseases

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

HealthPeak signs J&Js Janssen for Bay Area campus lease

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Johnson & Johnson: "overweight"

San Francisco (www.aktiencheck.de) - Rating-Update: Larry Biegelsen, Analyst von Wells Fargo Advisors, bewertet die Aktie von Johnson & Johnson (ISIN: US4781601046,…

Johnson & Johnson (JNJ) Gains But Lags Market: What You Should Know

In the latest trading session, Johnson & Johnson (JNJ) closed at $145.39, marking a +0.3% move from the previous day....…

Kaleido Bio teams up with J&J to identify microbiome metabolic candidates

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Johnson & Johnson-Aktie könnte an den Widerstand bei 148,32 USD ansteigen - Chartanalyse

Paris (www.aktiencheck.de) - Johnson & Johnson-Aktie könnte an den Widerstand bei 148,32 USD ansteigen - Chartanalyse Die Aktie von Johnson &…

JUST IN: A new study casts doubt that women who used talc baby powder or other personal-hygiene powders werent significantly more likely to develop ovarian cancer. The study could impact thousands of legal claims against drugmaker J&J over the

Um den gesamten Artikel unter trib.al zu lesen, klicken Sie bitte auf die Überschrift...…

Whats Driving Johnson & Johnsons Stock Price Growth-

Johnson & Johnsons (NYSE: JNJ) stock price grew 33% from around $105 levels by the end of 2016 to around…

Stocks making the biggest moves premarket: Boeing, Pfizer, Tesla, Pier 1, J&J, T-Mobile & more

These are the stocks posting the largest moves before the bell, including Boeing, Pfizer, Tesla, Pier 1, J&J, T-Mobile and…

Johnson & Johnson resolved a womans claims that asbestos-laced baby powder caused her cancer before a California jury got a chance to rule on the case

Um den gesamten Artikel unter trib.al zu lesen, klicken Sie bitte auf die Überschrift...…